Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01962688 · ClinicalTrials.gov registry record · NA
Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT01962688 is a NA study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 37 participants.
The verdict
NCT01962688, a NA study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to see if using a portable handheld ultrasound to guide diuretic therapy for heart failure patients will prevent hospital readmissions. This study will use a handheld ultrasound called a Vscan to look at a large vessel in the body called the Inferior Vena Cava (a vein leading to your heart) . The study aims to see whether changing diuretic therapy based on the size of this vessel will result in the less hospitalizations for heart failure patients as compared to just symptom guided therapy. This study is composed of two independent non-interacting trials-one in the outpatient setting and one in the inpatient setting.
Interventions
- DEVICE Handheld ultrasound
- DEVICE Sham ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01962688
The ClinicalTrials.gov registry entry for NCT01962688 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Handheld ultrasound is the first listed.
NCT01962688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01962688 about?
NCT01962688 is a clinical study titled "Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment". The purpose of this study is to see if using a portable handheld ultrasound to guide diuretic therapy for heart failure patients will prevent hospital readmissions. This study will use a handheld ultrasound called a Vscan to look at a large vessel in the body called the Inferior Vena Cava (a vein le...
What is the current status of trial NCT01962688?
This trial is currently terminated. It is a NA study. The enrollment target is 37 participants. The study started on 2013-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01962688?
The interventions under investigation include: Handheld ultrasound (DEVICE), Sham ultrasound (DEVICE).
Who is sponsoring clinical trial NCT01962688?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.